Skip to content
  • Tuesday, 29 September 2026
  • 5:02 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Ionis Pharmaceuticals and Recordati Forge Global Partnership for Zilganersen in Alexander Disease
Pharmaceutical R&D

Ionis Pharmaceuticals and Recordati Forge Global Partnership for Zilganersen in Alexander Disease

Teuku Ryan Jun 28, 2026 0

Ionis Pharmaceuticals has forged a significant global licensing agreement with Recordati, a prominent international pharmaceutical company, granting Recordati exclusive rights…

Read More
Breakthrough in Thermal Management at Oak Ridge National Laboratory Reveals Electric Field Control of Heat Flow in CeramicsGinkgo, Tangible and Inductive Bio aim to move ADME decisions from lead optimization to hit IDSingulonics and the Breakthrough of Narwhal-Shaped Wavefunctions in Dielectric NanophotonicsAnalyzing Natural Speech Patterns Provides Crucial Indicators of Brain Health and Executive Function Across the Lifespan
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must Have
Tolerance Bio Secures Exclusive Global Rights Outside Japan for Tanabe Pharma Anti-IL-33 Monoclonal Antibody TLB-33 in Landmark $560m DealUnprecedented Genetic Study Reveals Explosive Growth Rates and Origins of Chronic Myeloid Leukemia Years Before DiagnosisAs the dream of the autonomous clinical trial dawns, agent supervision is today’s human jobNew Research Identifies Peripheral Immune Pathway as a Critical Driver of Alzheimer’s Disease Neurodegeneration
YOU MAY HAVE MISSED
Pharmaceutical R&D
Tolerance Bio Secures Exclusive Global Rights Outside Japan for Tanabe Pharma Anti-IL-33 Monoclonal Antibody TLB-33 in Landmark $560m Deal
Teuku Ryan Sep 29, 2026
Stem Cell & Regenerative Medicine
Unprecedented Genetic Study Reveals Explosive Growth Rates and Origins of Chronic Myeloid Leukemia Years Before Diagnosis
Dwi Wanna Sep 29, 2026
Laboratory Automation & Robotics
As the dream of the autonomous clinical trial dawns, agent supervision is today’s human job
Lana Keisha Sep 29, 2026
Neuroscience & Brain Research
New Research Identifies Peripheral Immune Pathway as a Critical Driver of Alzheimer’s Disease Neurodegeneration
Rifan Muazin Sep 29, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ